comparemela.com

Latest Breaking News On - Peptidream inc stock exchange - Page 1 : comparemela.com

PeptiDream : Corporate Governance Report 07/04/2023 (618KB）

Corporate Governance Report Date of last revision: April 7, 2023 PeptiDream Inc. Patrick C. Reid Representative. | April 7, 2023

United statesPatrickc reidKiyofumi kaneshiroMichio sasaokaToshio nagaeJunko utsunomiyaSupervisory committee membersTokyo stock exchangeSupervisory committeeHuman resource developmentIr public affairs department securities codeCompany board of directorsSustainability promotion committeeParty transactionsPeptidream groupCompany directors

PeptiDream : Announces Achievement of Development Milestone in Discovery Alliance with Bayer(Press Release) (134KB）

News Release April 5, 2023 PeptiDream Inc https://www.peptidream.com . | April 5, 2023

Yuko okimotoPatrickc reidTokyo stock exchange prime sectionPeptidream inc codePeptidream announces achievement of development milestoneIr public affairsDiscovery alliancePeptidream incDream incDream announces achievementDevelopment milestoneGermany based bayerPeptide discovery platform systemPeptidream inc stock exchangePress releaseNc 4587 jp3836750004

PeptiDream : Corporate Presentation（English version) (2MB）

Corporate Presentation February 2023 PeptiDream Inc. . | February 20, 2023

University startup to growing japanUniversity of tokyoPeptidream equity holdingsDevelopment of macrocyclic peptide therapeuticsPeptidream incPdradiopharma incCorporate presentationMacrocyclic peptide therapeuticsPeptide discovery platform systemUniversity startupGrowing japan based drug discovery powerhousePrime marketStrategic ownership stakesPeptide related companiesDrug discoveryFactor business

PeptiDream : awarded Leadership level in CDP s 2022 Climate Change Report (87KB）

News Release January 10, 2023 PeptiDream Inc https://www.peptidream.com . | January 10, 2023

Patrickc reidPeptidream inc codePeptidream incTokyo stock exchange prime sectionDream incChange reportClimate changeWater securityCarbon disclosure projectPeptide discovery platform systemPeptidream inc stock exchangePress releaseNc 4587 jp3836750004

PeptiDream : Amolyt Pharma Announces Series C Financing

Lyon, France, and Cambridge, MA, January 6, 2023 - Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today. | January 10, 2023

United statesUnited kingdomToby sykesAshley robinsonAmolyt pharmaJordyn temperatoBpifrance investissementThierry abribatPamerican society for boneLifesci advisorsNovo holdings venturesCapital groupLifesci communicationsLife sciencesMineral researchTekla capital investment

vimarsana © 2020. All Rights Reserved.